2/2 Collaborative Study: Testosterone Augmentation in Women
2/2 合作研究:女性睾酮水平增强
基本信息
- 批准号:8875769
- 负责人:
- 金额:$ 21.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-24 至 2016-11-30
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAddressAdverse effectsAffectAndrogensAntidepressive AgentsAreaArousalCollaborationsDataData AnalysesDepressed moodDisease remissionDoseEndocrinologyFatigueFemaleFutureGlycolsHealthHormonesHospitalsInterventionIntervention StudiesJointsLibidoMajor Depressive DisorderMental DepressionMulticenter TrialsPatientsPharmaceutical PreparationsPhysiologicalPhysiological ProcessesPlacebosPopulationPostmenopausePsychiatristPsychiatryPublic HealthQuality of lifeRandomized Controlled TrialsRecording of previous eventsRecruitment ActivityResearchResearch Domain CriteriaResearch PersonnelResidual stateResistanceSample SizeSamplingSelective Serotonin Reuptake InhibitorSerotonin Uptake InhibitorsSeveritiesSex FunctioningSexual DysfunctionSiteStudy SubjectSymptomsTestingTestosteroneTherapeuticValidationWomanbasecareerdata managementdepressive symptomsdouble-blind placebo controlled trialdrug candidateeffective therapyefficacy testingexperiencehormone therapyimprovedinterestmultidisciplinarynovelopen labelpatient oriented researchrandomized placebo controlled trialresponsesuicidal risktreatment-resistant depression
项目摘要
DESCRIPTION (provided by applicant): Major depressive disorder is a significant public health problem, disproportionately affecting women. Approximately 70% of patients do not respond or only partially respond to standard SSRI treatment despite adequate dosing. In our open-label pilot data, two-thirds of women with major depressive disorder who were resistant or partially resistant to antidepressants achieved a response to very low-dose, physiologic transdermal testosterone administration; one-third of women treated achieved remission after 8 weeks of therapy, with no hyperandrogenic side effects. We propose a collaborative, randomized, placebo-controlled trial to determine whether larger, multi-center trials are indicated
to investigate whether low-dose testosterone is an efficacious and well-tolerated augmentation strategy in women with major depressive disorder and SSRI partial/nonresponse. We propose a collaborative, multidisciplinary study from two academic medical centers in order to increase sample size, accelerate recruitment and increase sample diversity.
描述(由申请人提供):严重抑郁障碍是一个严重的公共卫生问题,对女性的影响不成比例。大约70%的患者对标准的SSRI治疗没有反应或只有部分反应,尽管剂量足够。在我们的开放标签试验数据中,三分之二对抗抑郁药物耐药或部分耐药的患有严重抑郁障碍的女性对极低剂量的生理性经皮睾酮治疗有反应;三分之一的接受治疗的女性在治疗8周后获得缓解,没有高雄激素副作用。我们建议进行一项协作性、随机性、安慰剂对照试验,以确定是否需要更大规模的多中心试验。
目的:研究小剂量睾酮对患有严重抑郁障碍和SSRI部分/无反应的女性是否有效和耐受性良好的强化治疗策略。我们建议从两个学术医学中心进行一项合作的、多学科的研究,以增加样本量,加速招募,并增加样本多样性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINDA L CARPENTER其他文献
LINDA L CARPENTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LINDA L CARPENTER', 18)}}的其他基金
2/2 Collaborative Study: Testosterone Augmentation in Women
2/2 合作研究:女性睾酮水平增强
- 批准号:
8706239 - 财政年份:2013
- 资助金额:
$ 21.11万 - 项目类别:
2/2 Collaborative Study: Testosterone Augmentation in Women
2/2 合作研究:女性睾酮水平增强
- 批准号:
8588635 - 财政年份:2013
- 资助金额:
$ 21.11万 - 项目类别:
DEX/CRH Response: Mood/Anxiety Disorder Endophenotype?
DEX/CRH 反应:情绪/焦虑症内表型?
- 批准号:
6773425 - 财政年份:2004
- 资助金额:
$ 21.11万 - 项目类别:
Dex/CRH Response: Mood/Anxiety Disorder Endophenotype?
Dex/CRH 反应:情绪/焦虑症内表型?
- 批准号:
8066297 - 财政年份:2004
- 资助金额:
$ 21.11万 - 项目类别:
Dex/CRH Response: Mood/Anxiety Disorder Endophenotype?
Dex/CRH 反应:情绪/焦虑症内表型?
- 批准号:
8440345 - 财政年份:2004
- 资助金额:
$ 21.11万 - 项目类别:
Dex/CRH Response: Mood/Anxiety Disorder Endophenotype?
Dex/CRH 反应:情绪/焦虑症内表型?
- 批准号:
7893657 - 财政年份:2004
- 资助金额:
$ 21.11万 - 项目类别:
Dex/CRH Response: Mood/Anxiety Disorder Endophenotype?
Dex/CRH 反应:情绪/焦虑症内表型?
- 批准号:
7730258 - 财政年份:2004
- 资助金额:
$ 21.11万 - 项目类别:
Dex/CRH Response: Mood/Anxiety Disorder Endophenotype?
Dex/CRH 反应:情绪/焦虑症内表型?
- 批准号:
8299128 - 财政年份:2004
- 资助金额:
$ 21.11万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 21.11万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 21.11万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 21.11万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 21.11万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 21.11万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 21.11万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 21.11万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 21.11万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 21.11万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 21.11万 - 项目类别:
Research Grant